116 related articles for article (PubMed ID: 15946243)
1. Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis.
Willers J; Lucchese A; Mittelman A; Dummer R; Kanduc D
Exp Dermatol; 2005 Jul; 14(7):543-50. PubMed ID: 15946243
[TBL] [Abstract][Full Text] [Related]
2. Proteomic scan for tyrosinase peptide antigenic pattern in vitiligo and melanoma: role of sequence similarity and HLA-DR1 affinity.
Lucchese A; Willers J; Mittelman A; Kanduc D; Dummer R
J Immunol; 2005 Nov; 175(10):7009-20. PubMed ID: 16272362
[TBL] [Abstract][Full Text] [Related]
3. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
[TBL] [Abstract][Full Text] [Related]
4. Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity.
Tiwari R; Geliebter J; Lucchese A; Mittelman A; Kanduc D
Peptides; 2004 Nov; 25(11):1865-71. PubMed ID: 15501517
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies produced against murine tyrosinase identify pigmented human melanocytes.
Tomita Y; Hearing VJ
Diagn Immunol; 1986; 4(3):149-54. PubMed ID: 3089671
[TBL] [Abstract][Full Text] [Related]
6. Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
J Invest Dermatol; 1999 Aug; 113(2):267-71. PubMed ID: 10469315
[TBL] [Abstract][Full Text] [Related]
7. T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.
Jungbluth AA; Iversen K; Coplan K; Kolb D; Stockert E; Chen YT; Old LJ; Busam K
Pathol Res Pract; 2000; 196(4):235-42. PubMed ID: 10782467
[TBL] [Abstract][Full Text] [Related]
8. Degenerate binding of tyrosinase peptides to MHC II Ad/Ed molecules.
Mittelman A; Lucchese G; Stufano A; Kanduc D
J Exp Ther Oncol; 2007; 6(3):231-9. PubMed ID: 17552363
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo.
Fishman P; Merimski O; Baharav E; Shoenfeld Y
Cancer; 1997 Apr; 79(8):1461-4. PubMed ID: 9118024
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
Chen YT; Stockert E; Tsang S; Coplan KA; Old LJ
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8125-9. PubMed ID: 7667256
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibody recognition of synthetic antigens from MUC1.
Bánóczi Z; Mezõ G; Windberg E; Uray K; Majer Z; Hudecz F
J Pept Sci; 2008 May; 14(5):610-6. PubMed ID: 17975847
[TBL] [Abstract][Full Text] [Related]
12. Identification of the immunodominant regions of the melanoma antigen tyrosinase by anti-tyrosinase monoclonal antibodies.
Jaanson N; Möll K; Kulla A; Ustav M
Melanoma Res; 2003 Oct; 13(5):473-82. PubMed ID: 14512789
[TBL] [Abstract][Full Text] [Related]
13. Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining.
Mittelman A; Tiwari R; Lucchese G; Willers J; Dummer R; Kanduc D
J Invest Dermatol; 2004 Oct; 123(4):670-5. PubMed ID: 15373771
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two cancer vaccines targeting tyrosinase: plasmid DNA and recombinant alphavirus replicon particles.
Goldberg SM; Bartido SM; Gardner JP; Guevara-Patiño JA; Montgomery SC; Perales MA; Maughan MF; Dempsey J; Donovan GP; Olson WC; Houghton AN; Wolchok JD
Clin Cancer Res; 2005 Nov; 11(22):8114-21. PubMed ID: 16299244
[TBL] [Abstract][Full Text] [Related]
15. Proteome-based epitopic peptide scanning along PSA.
Stufano A; Kanduc D
Exp Mol Pathol; 2009 Feb; 86(1):36-40. PubMed ID: 19109947
[TBL] [Abstract][Full Text] [Related]
16. [Expression and purification of epitope peptide of human tyrosinase and its antigenicity in vitiligo patients].
Guan CP; Zhou MN; Li YW; Wei XD; Xu AE
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2408-11. PubMed ID: 18036319
[TBL] [Abstract][Full Text] [Related]
17. NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope.
Kanduc D; Fanizzi FP; Lucchese G; Stevanovic S; Sinha AA; Mittelman A
Peptides; 2004 Feb; 25(2):243-50. PubMed ID: 15063005
[TBL] [Abstract][Full Text] [Related]
18. Tyrosinase as an autoantigen in patients with vitiligo.
Baharav E; Merimski O; Shoenfeld Y; Zigelman R; Gilbrud B; Yecheskel G; Youinou P; Fishman P
Clin Exp Immunol; 1996 Jul; 105(1):84-8. PubMed ID: 8697641
[TBL] [Abstract][Full Text] [Related]
19. Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis.
Polimeno L; Mittelman A; Gennero L; Ponzetto A; Lucchese G; Stufano A; Kusalik A; Kanduc D
Amino Acids; 2008 Apr; 34(3):479-84. PubMed ID: 17458624
[TBL] [Abstract][Full Text] [Related]
20. The role of tyrosinase in autoimmune vitiligo.
Song YH; Connor E; Li Y; Zorovich B; Balducci P; Maclaren N
Lancet; 1994 Oct; 344(8929):1049-52. PubMed ID: 7934446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
